Gourmetceuticals, LLC, a company that markets organically derived and scientifically validated ingredients, today announced the company’s collaboration with specialty pharmaceuticals company, Curamedics Pharmaceuticals, Inc. The alliance institutes the first collaboration between the two companies to co-develop functional food products for the human and veterinary markets, with royalties paid to Gourmetceuticals upon the sale of products.
“This collaboration aligns well with Gourmetceuticals’ mission to provide high quality ingredients in products that consumers can easily fit into their daily regimens,” said Garrett Lindemann, Ph.D., CEO of Gourmetceuticals. “The products will provide consumers with added health benefits that are backed by more than 20 years of clinical studies, which support the ingredients’ safety and efficacy.”
Terms of the deal include utilizing both of Gourmetceuticals’ ingredients, PPL-240™, an antioxidant with photoprotective properties, and GLPH-1™, an immune booster. The companies will co-develop a beverage, candy and chewable wafers for the human market as well as animal treats for the canine and equine markets. Products are expected to launch nationally in 2009.
“Curamedics made a strategic decision to collaborate with Gourmetceuticals as we enter the growing health and wellness market because of its scientifically validated ingredients,” said Dave Baj, CEO of Curamedics Pharmaceuticals. “We look forward to a long term partnership with Gourmetceuticals and to co-developing unique, premium products.”
Further details of the agreement, including commercial distribution of the products and associated health claims, will be disclosed upon the launch of the products.
Gourmetceuticals, LLC is a research-based culinary technology company that markets organically derived and scientifically tested ingredients for use in foods and beverages. Its ingredients, GLPH-1™ and PPL-240™, can transform human and veterinary products into gourmet functional foods and are FDA approved for human and animal consumption, GRAS affirmed, kosher and meet current Good Manufacturing Practices (cGMP) as outlined by the FDA. GLPH-1 is a polysaccharide extract from botanical yeast that promotes immune health and PPL-240 is an antioxidant derived from a South American fern that has been shown clinically to reduce damage from UVA and UVB rays. Both ingredients have been subject to more than 20 clinical trials that evaluated and supported their safety and effectiveness in humans and animals. For more information, visit the Company Web site at HYPERLINK "http://www.gourmetceuticals.com" www.gourmetceuticals.com.
About Curamedics Pharmaceuticals, Inc.
Curamedics is a fully integrated specialty pharmaceutical company whose operating subsidiaries and affiliates provides branded products, excellent service and innovative technologies to the global healthcare industry. Our business leverages the expertise and experience of our management team, research and development, manufacturing capabilities and partnerships. A balanced strategy including new product development, growth of existing brands, acquisition and strategic collaborations, will drive our future growth. The company’s products have scientific and clinical performance that meets our high standards for best in class patient care. HYPERLINK "http://curamedicsrx.com/" http://curamedicsrx.com/